• Profile
Close

Variations in clinical presentation and biomarkers amongst biopsy-proven Lupus Nephritis patients: A Top-End retrospective cohort study

Internal Medicine Journal Oct 29, 2021

Xu C, Clarke C, Goh KL, et al. - The finding that lupus in Aboriginal and Torres Strait Islander Australians were of a ‘distinct phenotype’ vs non-Indigenous Australians is further supported.

  • In Australia, Aboriginal and Torres Strait Australians had previously shown higher incidence and prevalence of systemic lupus erythematosus vs non-Indigenous Australians.

  • This study included 33 consecutive biopsy proven lupus nephritis (LN) patients, 26 self-identified as of Aboriginal and Torres Strait Islander descent.

  • LN incidence were 5.08 and 0.47 per 100,000 patient years in Aboriginal and Torres Strait Islander Australian and non-Indigenous Australians, respectively.

  • In Indigenous Australian patients vs non-Indigenous Australian patients, more frequent were neurological (23.08% vs 0%) and hematological manifestations (46.50 % vs 16.67) as well as right heart catheter proven pulmonary arterial hypertension (23.08% vs 0%).

  • Indigenous Australian patients also showed higher incidence of positive Extractable Nuclear Antigen (84.62% vs 57.14%).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay